KUALA LUMPUR: RHB Research has maintained its Buy call on Karex with a target price of RM3.43 pegged to a 20 times CY15 P/E and implying a 19.5% upside.
"ONEbrand from GP is a top-four condom brand in the US and Karex believes the potential market in Asia is huge. We did a simple illustration on how Karex can improve its earnings through expansion in its OBM segment," it said.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
